术后放疗后PET/CT预测头颈癌治疗结局
阳性PET/CT患者3年总生存率仅11.2%,阴性者为89.9%(log rank p < 0.001);PET/CT对局部复发、区域复发和远处转移的阳性预测值均为100%。结论认为术后放疗后PET/CT可预测生存结局并早期检出复发。
要点
- 术后放疗后PET/CT阳性者3年OS为11.2%,阴性者为89.9%(p < 0.001)。
- PET/CT对局部复发、区域复发和远处转移的阳性预测值均为100%。
- 神经周围侵犯、p16状态、非口咽原发部位及化疗使用是PET/CT阳性的独立预测因素。
核心结论
- 术后放疗后PET/CT对生存结局具有预后价值,阳性预测值优异,可早期发现复发。
研究设计与样本
- PET/CT阳性基于多学科 review 整合临床信息判定,生存分析采用Kaplan-Meier法。
主要发现
- 中位随访3.88年,全部患者3年OS和RFS分别为71.8%和61.3%。
- 阳性PET/CT患者3年OS为11.2%,阴性者为89.9%(log rank p < 0.001)。
- PET/CT对局部复发、区域复发和远处转移的阳性预测值均为100%,阴性预测值分别为89.0%、89.2%和85.9%。
- 神经周围侵犯(p = 0.009)、p16状态(p = 0.009)、非口咽原发部位(p = 0.002)和化疗使用(p = 0.01)是PET/CT阳性的独立预测因素。
关键数值与推荐
- PET/CT阳性判定基于多学科 review 整合临床信息。
- 统计学显著性设定为p ≤ 0.05。
临床怎么用
- 术后放疗后应考虑行PET/CT,以预测生存结局并早期检出复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to retrospectively review the role of post-treatment (post-tx) FDG-PET/CT scans in patients receiving postoperative intensity-modulated radiotherapy (IMRT) for head and neck squamous cell carcinomas (HNSCC). MATERIALS AND METHODS: Eighty-two patients with HNSCC treated with surgery and postoperative IMRT with or without chemotherapy from October 15, 2008 to December 31, 2014 that had post-tx PET/CT within 6 months of completing IMRT were included. PET/CT was considered positive based on multi-disciplinary review integrating clinical information. Survival analysis was performed using the Kaplan-Meier method. Categorical and continuous predictors of positive post-tx PET/CT were evaluated using Fisher's exact test and logistic regression, respectively. Predictors for survival outcomes were evaluated with log-rank testing. A p ≤ 0.05 was considered statistically significant. RESULTS: Median follow-up was 3.88 years. For all patients, 3-year overall survival (OS) and recurrence-free survival (RFS) were 71.8% and 61.3%, respectively. Patients with positive post-tx PET/CT had worse OS compared to those with negative post-tx PET/CT (log rank p < 0.001). For patients with positive post-tx PET/CT, 3-year OS was 11.2% compared to 89.9% for patients with negative post-tx PET/CT. The positive predictive value (PPV) of PET/CT was 100% for local recurrence (LR), regional recurrence (RR) and distant metastasis (DM). The negative predictive values (NPV) for LR, RR and DM were 89.0%, 89.2%, and 85.9%, respectively. Perineural invasion (p = 0.009), p16 status (p = 0.009), non-oropharyngeal primary site (p = 0.002), and the use of chemotherapy (p = 0.01) were independent predictors of positive PET/CT. CONCLUSIONS: Post-tx PET/CT after postoperative radiation is prognostic for survival outcomes. The PPV of post-tx PET for recurrence was excellent, allowing for early detection of recurrent disease. Post-tx PET/CT should be considered after postoperative radiation.
引用
- Li Y, Awan MJ, Chang T, et al. Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy. Eur J Nucl Med Mol Imaging. 2019. PMID: 30680587. doi:10.1007/s00259-019-4272-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。